Skip to main content
Log in

Cost-effectiveness modelling in T2DM: comparison of two models

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Willis M, et al. Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM. PharmacoEconomics : 13 May 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00922-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost-effectiveness modelling in T2DM: comparison of two models. PharmacoEcon Outcomes News 854, 14 (2020). https://doi.org/10.1007/s40274-020-6844-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6844-z

Navigation